
Cardiac Wire #67 March 23, 2023
The Big Impact of Small Cardiorespiratory Changes | vMap Ablation’s Improved Outcomes

Cardiac Wire #66 March 20, 2023
Esperion’s Milestone Faceoff | TEER Outcomes

Cardiac Wire #65 March 16, 2023
Inflammation’s ASCVD Potential | Alerts Boost Adherence

Cardiac Wire #64 March 13, 2023
Young Adult Risks Predict CVD Tsunami | Pacemaker Harvest

Cardiac Wire #63 March 9, 2023
Top 8 of ACC 2023 | Esperion’s CLEAR Outcomes

Cardiac Wire #62 March 6, 2023
Low LDL-C Benefits | More RDN Evidence

Cardiac Wire #61 March 2, 2023
Novice Heart Failure Screening | Renal Denervation’s Comeback

Cardiac Wire #60 February 27, 2023
LDL-TG’s Atherosclerosis Impact | Sad LAAO Science

Cardiac Wire #59 February 21, 2023
Lasting CV Risks After Complicated Pregnancies | JACC Editor Interviews ChatGPT

Cardiac Wire #58 February 16, 2023
GE Acquires Caption Health | Aspirin Risks Exceed Benefits

Cardiac Wire #57 February 13, 2023
Biosense Webster’s PFA Milestone | Forxiga’s Expanded Approval

Cardiac Wire #56 February 9, 2023
Challenging the HFpEF Treatment Dogma | Heart Disease Risk Perceptions

Cardiac Wire #55 February 6, 2023
The Power of Low Lifelong LDL-C | Abbott’s Catheter Ablation Approvals

Cardiac Wire #54 February 2, 2023
Echo AI Model for CAC Scoring | Eli Lilly Bolsters Manufacturing for GLP-1 Agonists

Cardiac Wire 53 January 30, 2023
AVS Series B | Wearable Cardiac Ultrasound

January 26, 2023
Improving Chest Pain Triage | Empagliflozin’s CKD Impact

Cardiac Wire #51 January 23, 2023
Intermittent Fasting Long Term? | Abbott’s Next-Gen Device Approval

Cardiac Wire #50 January 19, 2023
CAPLA: Simple Ablation is Best | Shockwave Acquires Neovasc

Cardiac Wire #49 January 16, 2023